context: Pork still sits at the heart of PRC meat demand. Drug residue risk starts on farms, but it tests the whole supply chain. For a meat group at the scale of Wangkui Shuanghui Beidahuang Food Co Ltd, meeting the bare test list is not enough. The latest case shows how food safety checks are pushing large processors to move from after-the-fact replies to tighter risk control at source.
A recent food safety notice in Heilongjiang found a batch of pork rump meat made by Wangkui Shuanghui Beidahuang Food Co Ltd had too much lincomycin. The test result was 7,700μg/kg. The national limit is 200μg/kg. That means the residue was close to 38 times the legal cap.
Lincomycin is a lawful vet drug. It is used to treat lung and gut infections in pigs. The issue is not the drug itself. The issue is whether farms stick to the withdrawal period before slaughter. Pigs must be taken off the drug long enough for residues to fall below the safe limit. If farms overuse the drug, or send pigs to slaughter too soon, the meat can fail safety tests.
Shuanghui said the fault lay mainly with the upstream farms, which had not followed the rules on withdrawal periods. It also said lincomycin is not a must-test item for meat leaving the slaughter stage. That claim has some ground. Lincomycin is not a banned drug, and it draws less scrutiny than higher-risk drugs such as clenbuterol.
But that does not clear Shuanghui of fault. Food makers are the first line of blame for food safety. Under the Food Safety Law, they must check suppliers, check proof of quality, test raw materials where needed, and keep unsafe inputs out of production. For a slaughter and meat group, this means supplier checks, intake checks, batch tests and risk screening.
The key question is why Shuanghui did not spot the risk sooner? A result almost 38 times above the cap is not a small breach. It is a clear warning sign. As an industry leader, Shuanghui should have stronger tools to screen suppliers, trace batches and test for drug residues. Even if lincomycin is not on the must-test list, it should still be tested where the risk is high.
Cost often shapes what firms choose to test. Each extra test brings more sampling, staff time, records and follow-up work. But food safety cannot run on the lowest legal bar alone. For high-risk suppliers, peak disease seasons, odd batches and key sourcing areas, firms should step up testing. They should not assume that every farm has followed the rules.
The case also shows that risk in the meat trade does not sit only on farms. Loose drug use and weak withdrawal rules at farm level are real problems. But a branded processor cannot treat itself as a mere slaughterhouse. Once the product reaches the market, shoppers see the Shuanghui name. A large brand that gains from scale and reach must also bear a higher duty across its supply chain.
Shuanghui said the batch was made in August 2025 and is no longer on sale. It also said it will tighten supplier checks and test more often for vet drug residues. The next step should be clearer: how far it has traced the issue, how often it will test, and how it will deal with weak suppliers. Food safety is not a public relations task after a breach. It is front-end risk control. Not being on the must-test list does not mean not being worth testing.